CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Enteryxdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00346905
NCT00346905N/ACompleted
CompareCT.gov

Endoscopic Implantation of Enteryx for the Treatment of Gastroesophageal Reflux Disease (GERD): Post Market Study

Beth Israel Deaconess Medical Center·interventional·Posted Jun 30, 2006·Updated Jul 21, 2017

In Brief

A clinical study evaluating Enteryx for Gastroesophageal Reflux. Completed, enrolled 16 participants across 1 site.

Detailed Summary

The study objective is to assess the long term safety and effectiveness of Enteryx device in commercial use. The long-term effects beyond one year of treatment with Enteryx have not been established.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 30, 2006
Enrollment StartOct 1, 2003
Primary CompletionFeb 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 20.0 years ago

Interventions

Enteryxdrug